findmyKOL

Paul Kaywin, MD

Basic profile

Baptist Hospital of Miami

ORCIDNone on fileNPI
RegionMiami, FL · SoutheastSpecialtyHematology / OncologyFocusOncology
Last active 2024findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Paul Kaywin is an Oncology physician affiliated with Baptist Hospital of Miami. OpenAlex indexes 14 publications with 619 citations (h-index 8).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
14publications

Distinct works indexed by OpenAlex.

619citations

Total citations across indexed works.

8h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
16companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

8900 N Kendall Dr
Miami Cancer Institute
Miami, FL 331762118

Telephone

786-596-2000

Provider last certified this registry record 30 Mar 2021.

View the NPPES registry record

Industry payments

16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    32.8%
    Kinase inhibitor27.4%
    Tagrisso100%
    Part D<11 patients
    Antimetabolite5.4%
    Hydroxyurea100%
    Part D<11 patients
  • Metabolism & gastrointestinal

    24.5%
    Serotonin-3 Receptor Antagonist12.4%
    Ondansetron Hcl100%
    Part D19 patients
    Antidiarrheal microorganisms12%
    Folic Acid100%
    Part D<11 patients
  • Sensory organs

    19.1%
    Corticosteroid19.1%
    Dexamethasone100%
    Part D27 patients
Where care is delivered (Part B)46.5% facility · 53.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”